Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: J Heart Lung Transplant. 2019 Nov 26;39(5):441–453. doi: 10.1016/j.healun.2019.11.016

Table 6.

Estimated survival based on blood pressure group in patients on hydrodynamic centrifugal flow LVAD support. Patient average blood pressure was calculated from measures obtained month 3 and onward after LVAD.

Estimated Survival (%) during Centrifugal Flow Support
90 day 1 Year 3 Year P
MAP Group, mmHg p = 0.063
 MAP ≤75 (n at risk) 98.2 ± 0.7% (n=329) 89 ± 1.9% (n=320) 67 ± 4.7% (n=179) --
 MAP 76-90 (n at risk) 99.4 ± 0.3% (n=715) 91 ± 1.2% (n=708) 69± 3.2% (n=424) --
 MAP 91-100 (n at risk) 99.6 ± 0.4% (n=248) 94 ± 1.6% (n=244) 75 ± 5.9%(n=152) --
 MAP >100 (n at risk) 100% (n=55) 93 ± 3.6% (n=52) 81 ±7.5 (n=27) --
Doppler Group, mmHg p=0.038
 Doppler ≤80 (n at risk) 99.9 ± 0.1% (n=789) 88 ± 1.4% (n=773) 66± 3.7% (n=374) --
 Doppler 81-95 (n at risk) 99.9 ± 0.1% (n=1106) 93 ± 0.9% (n=1088) 69± 3.0% (n=636) --
 Doppler 96-105 (n at risk) 100% (n=188) 90 ± 2.5% (n=185) 73 ± 5.8% (n=104) --
 Doppler >105 (n at risk) 100% (n=64) 90 ± 4.1% (n=63) 84 ± 7.0% (n=399) --
SBP Group, mmHg p=0.018
 SBP <90 (n at risk) 99.0 ± 0.5% (n=387) 89 ± 1.8% (n=380) 66 ± 4.7% (n=203)
 SBP 90-107 (n at risk) 99.7 ± 0.2%(n=711) 93 ± 1.1% (n=707) 74 ± 3.1% (n=415)
 SBP 108-119 (n at risk) 99.6 ± 0.4% (n=258) 91 ± 1.9% (n=254) 60 ± 6.3% (n=155)
 SBP ≥120 (n at risk) 100% (n=108) 93 ± 2.7% (n=106) 79 ± 6.8% (n=61)